GoAI
Get started
The Cooper Companies, Inc. logo

The Cooper Companies, Inc.

COO

NASDAQHealthcareMedical - Instruments & Supplies

Open in GoAI

Previous close

$76.22

+$0.06 · +0.08%

Aug 21, 4:00 PM ET

COO company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

56

Fair Value

Momentum

39

Weakening

Sentiment

59

Mixed

Risk resilience

64

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
Headquarters
US
CEO
Albert G. White
Listed since
Jan 21, 1983
Employees
15,000

Market position

Day range

Current $76.22

52-week range

Current $76.22

Open
$76.23
Previous close
$76.16
Volume
1.55M
0.6× average
Average volume
2.59M
Average daily volume
Market cap
14.87B USD
Beta
0.82
Market reference 1
50-day average
$71.8356
+6.10% above average
200-day average
$73.3543
+3.91% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
16.66B USD
P/E (TTM)
64.59×
P/B (TTM)
1.8×
P/S (TTM)
3.51×
EV / EBITDA
15.81×
Earnings yield
2.68%
Free cash flow yield
3.10%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
64.37%
Operating margin
11.77%
Net margin
5.57%
Return on equity
4.55%
Return on assets
3.02%
Return on invested capital
3.98%

Financial health

Debt / equity
0.3×
Current ratio
1.89×
Altman Z-score
3.48
Piotroski F-score
8 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends110%73%36%-1%Gross margin, FY2021: 66.92%Gross margin, FY2022: 64.67%Gross margin, FY2023: 65.62%Gross margin, FY2024: 66.64%Gross margin, FY2025: 60.67%Operating margin, FY2021: 17.31%Operating margin, FY2022: 15.34%Operating margin, FY2023: 14.84%Operating margin, FY2024: 18.12%Operating margin, FY2025: 16.69%Net margin, FY2021: 100.76%Net margin, FY2022: 11.66%Net margin, FY2023: 8.19%Net margin, FY2024: 10.07%Net margin, FY2025: 9.16%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 66.92%. Gross margin FY2022 64.67%. Gross margin FY2023 65.62%. Gross margin FY2024 66.64%. Gross margin FY2025 60.67%. Operating margin FY2021 17.31%. Operating margin FY2022 15.34%. Operating margin FY2023 14.84%. Operating margin FY2024 18.12%. Operating margin FY2025 16.69%. Net margin FY2021 100.76%. Net margin FY2022 11.66%. Net margin FY2023 8.19%. Net margin FY2024 10.07%. Net margin FY2025 9.16%.

Income trends

Revenue

4.09B USD+5.06%

Operating income

682.9M USD-3.23%

Net income

374.9M USD-4.44%
Income trends across reported periods4.47B USD2.95B USD1.43B USD−85.62M USDRevenue, FY2021: 2.92B USDRevenue, FY2022: 3.31B USDRevenue, FY2023: 3.59B USDRevenue, FY2024: 3.9B USDRevenue, FY2025: 4.09B USDOperating income, FY2021: 505.8M USDOperating income, FY2022: 507.6M USDOperating income, FY2023: 533.1M USDOperating income, FY2024: 705.7M USDOperating income, FY2025: 682.9M USDNet income, FY2021: 2.94B USDNet income, FY2022: 385.8M USDNet income, FY2023: 294.2M USDNet income, FY2024: 392.3M USDNet income, FY2025: 374.9M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 2.92B USD. Revenue FY2022 3.31B USD. Revenue FY2023 3.59B USD. Revenue FY2024 3.9B USD. Revenue FY2025 4.09B USD. Operating income FY2021 505.8M USD. Operating income FY2022 507.6M USD. Operating income FY2023 533.1M USD. Operating income FY2024 705.7M USD. Operating income FY2025 682.9M USD. Net income FY2021 2.94B USD. Net income FY2022 385.8M USD. Net income FY2023 294.2M USD. Net income FY2024 392.3M USD. Net income FY2025 374.9M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue4.09B USD3.9B USD3.59B USD3.31B USD2.92B USD
Cost of goods sold1.61B USD1.3B USD1.24B USD1.17B USD966.7M USD
Gross profit2.48B USD2.6B USD2.36B USD2.14B USD1.96B USD
Research and development172.2M USD155.1M USD137.4M USD110.3M USD92.7M USD
Selling, general, and administrative1.63B USD1.53B USD1.5B USD1.34B USD1.21B USD
Operating expenses1.8B USD1.89B USD1.82B USD1.63B USD1.45B USD
Interest expense100M USD114.3M USD105.3M USD57.3M USD23.1M USD
Depreciation and amortization423M USD375.1M USD367.7M USD346.1M USD309.3M USD
Operating income682.9M USD705.7M USD533.1M USD507.6M USD505.8M USD
Net income374.9M USD392.3M USD294.2M USD385.8M USD2.94B USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
91%
10 beats, 0 misses, 1 met estimate
Average EPS surprise
+4.34%
11 comparable reports
Latest EPS result
1.21
Estimate 1.1 · Beat by 10.00%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates1.261.1310.87Q4 '24BeatQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26Estimate
Q4 2024, reported Dec 5, 2024: actual 1.04, estimate 1, surprise +4.00%, Beat. Q1 2025, reported Mar 6, 2025: actual 0.92, estimate 0.914, surprise +0.66%, Beat. Q2 2025, reported May 29, 2025: actual 0.96, estimate 0.928, surprise +3.45%, Beat. Q3 2025, reported Aug 27, 2025: actual 1.1, estimate 1.07, surprise +2.80%, Beat. Q4 2025, reported Dec 4, 2025: actual 1.15, estimate 1.11, surprise +3.60%, Beat. Q1 2026, reported Mar 5, 2026: actual 1.1, estimate 1.03, surprise +6.80%, Beat. Q2 2026, reported Jun 4, 2026: actual 1.21, estimate 1.1, surprise +10.00%, Beat. Q3 2026, reported Sep 9, 2026: actual —, estimate 1.12, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates1.14B1.07B994.73M920.75MQ4 '24MissQ1 '25MissQ2 '25BeatQ3 '25MissQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26Estimate
Q4 2024, reported Dec 5, 2024: actual 1.02B USD, estimate 1.03B USD, surprise -0.82%, Miss. Q1 2025, reported Mar 6, 2025: actual 964.7M USD, estimate 978.09M USD, surprise -1.37%, Miss. Q2 2025, reported May 29, 2025: actual 1B USD, estimate 995.34M USD, surprise +0.70%, Beat. Q3 2025, reported Aug 27, 2025: actual 1.06B USD, estimate 1.06B USD, surprise -0.34%, Miss. Q4 2025, reported Dec 4, 2025: actual 1.07B USD, estimate 1.06B USD, surprise +0.42%, Beat. Q1 2026, reported Mar 5, 2026: actual 1.02B USD, estimate 1.02B USD, surprise +0.01%, Beat. Q2 2026, reported Jun 4, 2026: actual 1.08B USD, estimate 1.05B USD, surprise +2.63%, Beat. Q3 2026, reported Sep 9, 2026: actual —, estimate 1.1B USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$76.80

0.76% upside
Past 12 months12-month forecastHigh $86.00Average $76.80Low $61.00

Rating distribution

25 ratings
Strong buy00%
Buy1664%
Hold832%
Sell14%
Strong sell00%

Recent analyst actions

12 institutions
BNP ParibasmaintainOutperform

COO news

fool.com

Rigetti Computing's COO Sells Over 9,000 Company Shares. What Does That Mean for Investors?

The disposal of 9,038 shares was executed at a weighted average price of $16.79 per share, totaling ~$152,000. The transaction reduced the insider's direct equity position by 3% of previous holdings.

Read source
zacks.com

COO vs. MMSI: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Dental Supplies stocks have likely encountered both The Cooper Companies (COO) and Merit Medical (MMSI). But which of these two stocks is more attractive to value investors?

Read source
gurufocus.com

Target Corp (TGT) (Q2 2026) Earnings Call Highlights: Comparable Sales Surge 3.8% and Full-Year Guidance Raised

Net Sales: $26.5 billion, up 5.3% from last year.Comparable Sales: Increased 3.8%, driven by a 3.6% rise in traffic; average ticket was about flat.Store Compara

Read source
247wallst.com

Wendy's Jumps 5% on Nelson Peltz Take-Private Report, COO Role Revival

Shares of Wendy's (NASDAQ:WEN | WEN Price Prediction) are up 5% to $8.88 in midday trading Wednesday after reports that Nelson Peltz's Trian Fund Management is assembling a consortium to take the company private.

Read source
zacks.com

Here's Why The Cooper Companies (COO) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Read source
fool.com

Abercrombie & Fitch COO Scott Lipesky Sells 10,000 Shares for $1 Million

Disposed of 10,000 shares at $115.00 per share on August 10, 2026, representing $1.1 million in proceeds. Transaction reduced direct equity holdings by 6% to 152,534 shares.

Read source

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

$0.015

2023 complete year0.0% since 2019

Corporate action history

Dividend

Ex-dividend Jul 26, 2023

$0.03

Semi-Annual

Record Jul 27, 2023 · Payment Aug 11, 2023

Dividend

Ex-dividend Jan 20, 2023

$0.03

Semi-Annual

Record Jan 23, 2023 · Payment Feb 10, 2023

Dividend

Ex-dividend Jul 26, 2022

$0.03

Semi-Annual

Record Jul 27, 2022 · Payment Aug 11, 2022

Dividend

Ex-dividend Jan 20, 2022

$0.03

Semi-Annual

Record Jan 21, 2022 · Payment Feb 9, 2022

Dividend

Ex-dividend Jul 26, 2021

$0.03

Semi-Annual

Record Jul 27, 2021 · Payment Aug 11, 2021

Dividend

Ex-dividend Jan 21, 2021

$0.03

Semi-Annual

Record Jan 22, 2021 · Payment Feb 9, 2021

COO peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

ETFs holding COO

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
449.06M
Weight
0.02%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
Vanguard S&P 500 ETF logoVanguard S&P 500 ETFVOO
Market value
370.48M
Weight
0.02%
AUM
1.7T USD
Expense ratio
0.03%
Price / 1D
$703.71+0.39%
Vanguard Morningstar Small-Cap ETF logoVanguard Morningstar Small-Cap ETFVB
Market value
324.32M
Weight
0.17%
AUM
183.4B USD
Expense ratio
0.03%
Price / 1D
$304.76+0.64%
Invesco S&P 500 Equal Weight ETF logoInvesco S&P 500 Equal Weight ETFRSP
Market value
210.13M
Weight
0.21%
AUM
100.27B USD
Expense ratio
0.20%
Price / 1D
$221.67+0.63%
Vanguard Morningstar Small-Cap Value ETF logoVanguard Morningstar Small-Cap Value ETFVBR
Market value
206.03M
Weight
0.30%
AUM
68.3B USD
Expense ratio
0.05%
Price / 1D
$249.18+0.68%
iShares Core S&P 500 ETF logoiShares Core S&P 500 ETFIVV
Market value
200.26M
Weight
0.02%
AUM
891.84B USD
Expense ratio
0.03%
Price / 1D
$769.31+0.39%
State Street SPDR S&P 500 ETF logoState Street SPDR S&P 500 ETFSPY
Market value
184.76M
Weight
0.02%
AUM
817.87B USD
Expense ratio
0.09%
Price / 1D
$765.72+0.41%
State Street Health Care Select Sector SPDR ETF logoState Street Health Care Select Sector SPDR ETFXLV
Market value
106.89M
Weight
0.24%
AUM
44.76B USD
Expense ratio
0.08%
Price / 1D
$174.62+1.29%

Continue in GoAI

Research COO

research.disclaimer